share_log

HC Wainwright & Co. Reiterates Buy on ASLAN Pharma, Maintains $17 Price Target

HC Wainwright & Co. Reiterates Buy on ASLAN Pharma, Maintains $17 Price Target

HC Wainwright & Co.重申买入ASLAN Pharma,维持17美元的目标股价
Benzinga ·  2023/07/07 12:16

HC Wainwright & Co. analyst Yi Chen reiterates ASLAN Pharma (NASDAQ:ASLN) with a Buy and maintains $17 price target.

HC Wainwright & Co. 分析师陈毅重申ASLAN Pharma(纳斯达克股票代码:ASLN)为买入,并维持17美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发